ClearPoint Neuro Ownership | Who Owns ClearPoint Neuro?


OverviewRevenueFinancialsChartTranscripts

ClearPoint Neuro Ownership Summary


ClearPoint Neuro is owned by 32.40% institutional investors, 8.19% insiders, and 59.41% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.14% of CLPT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.87% of its assets in ClearPoint Neuro shares.

CLPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockClearPoint Neuro32.40%8.19%59.41%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryMedical Device Stocks52.08%10.61%37.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.73M6.14%$20.71M
Vanguard group1.25M4.52%$19.20M
Susquehanna group, llp509.16K1.85%$7.83M
Essex investment management408.82K1.48%$6.29M
Blackrock366.40K1.44%$1.97M
Brown advisory330.90K1.17%$3.95M
Cm management290.00K1.05%$4.46M
Millennium management289.15K1.05%$4.45M
D. e. shaw288.41K1.05%$4.44M
Geode capital management283.90K1.03%$4.37M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management290.00K3.98%$4.46M
Lane generational258.43K2.88%$3.09M
Cahill wealth management244.42K1.92%$3.76M
Taylor frigon capital management180.45K1.15%$2.15M
Essex investment management408.82K1.13%$6.29M
Legato capital management96.96K0.14%$1.16M
Entrypoint capital21.59K0.13%$257.74K
Epacria capital partners11.73K0.12%$140.04K
Parsons capital management inc/ri143.49K0.11%$1.71M
Pekin hardy strauss48.25K0.09%$742.09K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.73M0.00%1.32M
Susquehanna group, llp509.16K0.00%358.19K
Financial engines advisors250.35K0.01%250.35K
Goldman sachs group130.05K0.00%100.90K
Man group71.99K0.00%71.99K

Top Sellers

HolderShares% AssetsChange
Blackrock366.40K--1.11M
Invesco---247.98K
Qube research---163.01K
Jane street group---156.81K
Awm investment company---131.43K

New Positions

HolderShares% AssetsChangeValue
Financial engines advisors250.35K0.01%250.35K$2.99M
Man group71.99K0.00%71.99K$1.11M
Campbell & co investment adviser37.26K0.03%37.26K$444.82K
Colony group20.12K0.00%20.12K$240.27K
Intech investment management12.64K0.00%12.64K$150.93K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Northwestern mutual wealth management-8.00
Pom investment strategies-15.00
Nisa investment advisors-20.00
Smartleaf asset management-48.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025102-3.77%9,154,32911.74%323.71%6214.81%18-40.00%
Mar 31, 202510612.77%8,192,6637.73%293.89%5312.77%3172.22%
Dec 31, 202473-12.05%6,265,819-8.19%223.71%32-13.51%15-28.57%
Sep 30, 202483-4.60%6,824,887-3.20%243.22%38-21-4.55%
Jun 30, 2024861.18%7,050,688-6.46%272.95%38-2.56%224.76%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF804.25K2.87%-
Vanguard Total Stock Mkt Idx Inv808.67K2.85%-17.84K
iShares Russell 2000 ETF623.92K2.21%-11.87K
Rolnik Focus FIL500.00K1.77%-
Vanguard Institutional Extnd Mkt Idx Tr297.02K1.04%-128.57K
iShares Russell 2000 Growth ETF227.99K0.81%-
Invesco Dorsey Wright SmallCap Momt ETF187.18K0.68%-1.34K
Fidelity Extended Market Index143.16K0.51%-374.00
Vanguard Russell 2000 ETF123.86K0.44%-8.79K
State St Russell Sm Cap® Indx SL Cl I91.90K0.33%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 10, 2025Richards Timothy T.-Sell$132.80K
Jun 09, 2025BURNETT JOSEPH CEO and PresidentSell$282.37K
Jun 03, 2025FALLON LYNNETTE C-Sell$112.77K
Jun 03, 2025FALLON LYNNETTE C-Sell$15.46K
Aug 15, 2022BURNETT JOSEPH MICHAEL CEO and PresidentSell$303.19K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2-4
2025 Q1--
2024 Q4--
2024 Q3--

CLPT Ownership FAQ


Who Owns ClearPoint Neuro?

ClearPoint Neuro shareholders are primarily institutional investors at 32.40%, followed by 8.19% insiders and 59.41% retail investors. The average institutional ownership in ClearPoint Neuro's industry, Medical Device Stocks, is 52.08%, which ClearPoint Neuro falls below.

Who owns the most shares of ClearPoint Neuro?

ClearPoint Neuro’s largest shareholders are Blackrock funding, inc. /de (1.73M shares, 6.14%), Vanguard group (1.25M shares, 4.52%), and Susquehanna group, llp (509.16K shares, 1.85%). Together, they hold 12.51% of ClearPoint Neuro’s total shares outstanding.

Does Blackrock own ClearPoint Neuro?

Yes, BlackRock owns 1.44% of ClearPoint Neuro, totaling 366.4K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.97M$. In the last quarter, BlackRock decreased its holdings by -1.108M shares, a -75.14% change.

Who is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested?

Cm management is ClearPoint Neuro’s biggest shareholder by percentage of total assets invested, with 3.98% of its assets in 290K ClearPoint Neuro shares, valued at 4.46M$.

Who is the top mutual fund holder of ClearPoint Neuro shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of ClearPoint Neuro shares, with 2.87% of its total shares outstanding invested in 804.25K ClearPoint Neuro shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools